Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00293176 · ClinicalTrials.gov registry record · Phase 4
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
A Phase 4 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 4
- Development phase
- 821
- Enrollment target
NCT00293176: Completed Phase 4 study, sponsored by Eisai.
NCT00293176 is a Phase 4 study that has completed, run by Eisai. The registered enrollment target is 821 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00293176, a Phase 4 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 821 participants
- Enrollment target
Study Summary
To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
Interventions
- DRUG Placebo
- DRUG Donepezil Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 821 participants |
| Start Date | 2003-12 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00293176 record still lists
NCT00293176 is an interventional study that assigns participants to a tested intervention. The registered 821 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (58% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00293176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00293176 about?
NCT00293176 is a clinical study titled "The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)". To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
What is the current status of trial NCT00293176?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 821 participants. The study started on 2003-12. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00293176?
The interventions under investigation include: Placebo (DRUG), Donepezil Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00293176?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00293176's enrollment target sits among peer trials
821 95th of 2000 higher than 1,906 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05679349 · 822 participants · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
- NCT06091254 · 822 participants · Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- NCT07357389 · 822 participants · NA
Virtual Reality for ICU Delirium Prevention
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia